Amgen, Inc. (AMGN) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $402.98 -0.01%
EPS Growth %: +2.7%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.87, $0.07 worse than the analyst estimate of $1.94. Revenue for the quarter came in at $4.52 billion versus the consensus estimate of $4.76 billion.
For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
- Top power technology stocks for selective trading, says Oppenheimer
- RBC Capital maintains Outperform rating on Insmed amid CFO change
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
